Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant PDCD1 (Nivolumab Biosimilar) antibody

This Human Monoclonal antibody specifically detects PDCD1 (Nivolumab Biosimilar) in FACS, ELISA, SPR, BLI and Func. It exhibits reactivity toward Human.
Catalog No. ABIN7581618

Quick Overview for Recombinant PDCD1 (Nivolumab Biosimilar) antibody (ABIN7581618)

Target

PDCD1 (Nivolumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 2
  • 1
  • 1
  • 1
Human

Clonality

  • 3
  • 2
Monoclonal

Conjugate

  • 5
This PDCD1 (Nivolumab Biosimilar) antibody is un-conjugated

Application

  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS), ELISA, Surface Plasmon Resonance (SPR), Bio-Layer Interferometry (BLI), Functional Studies (Func)
  • Expression System

    CHO Cells

    Purpose

    Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nivolumab)

    Sequence

    QVQLVESGGG VVQPGRSLRL DCKASGITFS NSGMHWVRQA PGKGLEWVAV IWYDGSKRYY ADSVKGRFTI SRDNSKNTLF LQMNSLRAED TAVYYCATND DYWGQGTLVT VSSASTKGPS VFPLAPCSRS TSESTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TKTYTCNVDH KPSNTKVDKR VESKYGPPCP PCPAPEFLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN STYRVVSVLT VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW QEGNVFSCSV MHEALHNHYT QKSLSLSLGK ,EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD ASNRATGIPA RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ SSNWPRTFGQ GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    Characteristics

    Anti-PDCD1 / PD-1 / CD279 Reference Antibody (nivolumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG4 S228P
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: PD-1 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    PDCD1 (Nivolumab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa

    UniProt

    Q15116
You are here:
Chat with us!